Business Strategy
Drug development proceeds from the search for drug candidates to the determination of lead compounds, non-clinical testing and clinical testing.
We are a ‘drug discovery company’ that applies for and obtains patents for lead compounds and develops them up to non-clinical and early-stage clinical trials, after which we co-develop or licence them to interested domestic and overseas pharmaceutical companies for drug discovery.
- ・We will collaborate with highly specialised researchers to conduct the study and development of unique drugs.
- ・Our aim is to develop first-in-class drugs by confirming their pharmacological effects in animal models.
- ・We will licence our products to pharmaceutical companies both domestically and internationally.
Collaborative research
Aetas Pharma is currently collaborating with domestic and international research institutions on the development of M201-A and other new drugs.